Noxopharm Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Gisela Mautner
Chief executive officer
AU$491.6k
Total compensation
CEO salary percentage | 83.4% |
CEO tenure | 2.6yrs |
CEO ownership | n/a |
Management average tenure | 3.7yrs |
Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Here's Why We're Watching Noxopharm's (ASX:NOX) Cash Burn Situation
Aug 24Is Noxopharm (ASX:NOX) In A Good Position To Deliver On Growth Plans?
Jan 04We're Keeping An Eye On Noxopharm's (ASX:NOX) Cash Burn Rate
Jul 22Is Noxopharm (ASX:NOX) In A Good Position To Deliver On Growth Plans?
Feb 27We Think Noxopharm (ASX:NOX) Can Easily Afford To Drive Business Growth
Nov 10Is Noxopharm (ASX:NOX) Using Debt Sensibly?
Jun 04Noxopharm (ASX:NOX) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Feb 17These 4 Measures Indicate That Noxopharm (ASX:NOX) Is Using Debt Extensively
Sep 04CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -AU$4m |
Mar 31 2024 | n/a | n/a | -AU$8m |
Dec 31 2023 | n/a | n/a | -AU$12m |
Sep 30 2023 | n/a | n/a | -AU$14m |
Jun 30 2023 | AU$492k | AU$410k | -AU$15m |
Mar 31 2023 | n/a | n/a | -AU$15m |
Dec 31 2022 | n/a | n/a | -AU$15m |
Sep 30 2022 | n/a | n/a | -AU$17m |
Jun 30 2022 | AU$1m | AU$201k | -AU$19m |
Compensation vs Market: Gisela's total compensation ($USD329.40K) is about average for companies of similar size in the Australian market ($USD305.54K).
Compensation vs Earnings: Gisela's compensation has been consistent with company performance over the past year.
CEO
Gisela Mautner
2.6yrs
Tenure
AU$491,562
Compensation
Dr. Gisela Mautner is Non-Executive Director of Nyrada Inc. from August 1, 2022. She serves as Director at Noxopharm Limited. She served as Chief Medical Officer at Noxopharm Limited since October 2019 unt...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, Executive MD & Director | 2.6yrs | AU$491.56k | no data | |
Chief Financial Officer | 5.4yrs | no data | no data | |
Chief Operating Officer | 4.7yrs | no data | no data | |
Chief Scientific Officer of Oncology | 2.7yrs | no data | no data | |
Chief Scientific Officer of Inflammation | 2.7yrs | no data | no data | |
Company Secretary | 7.7yrs | AU$16.49k | no data |
3.7yrs
Average Tenure
Experienced Management: NOX's management team is considered experienced (3.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, Executive MD & Director | no data | AU$491.56k | no data | |
Non-Executive Chairman | 4.3yrs | AU$45.00k | 2.57% A$ 735.8k | |
Non-Executive Deputy Chairman | 8.5yrs | AU$60.00k | 0.31% A$ 88.2k | |
Non-Executive Director | 4.5yrs | AU$56.69k | 0.22% A$ 61.7k |
4.5yrs
Average Tenure
70yo
Average Age
Experienced Board: NOX's board of directors are considered experienced (4.5 years average tenure).